Abstract
IntroductionSomatostatin has antitumour activity in animal models of hepatocellular carcinoma. In human studies both favourable and unfavourable results have been reported. A 40% fraction of treated patients are benefited. Since...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have